Multiple Sclerosis News Today46m
Foralumab Phase 2a trial starts dosing patients at Yale MS Center
A Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS has dosed the first patients enrolled at Yale MS Center.
US FDA declines to approve Milestone's heart rhythm nasal spray
The U.S. Food and Drug Administration has declined to approve Milestone Pharmaceuticals' nasal spray to treat a type of heart ...
FDA Rejects Milestone Pharmaceuticals' Etripamil Nasal Spray
The Food and Drug Administration has turned away a proposed nasal spray from Milestone Pharmaceuticals to treat a type of irregular heartbeat over concerns about how the drug is manufactured.
Fierce Pharma3h
Manufacturing issues trip up Milestone's long-awaited FDA landmark
Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has been a ...
FDA recalls SinuCleanse nasal wash due to potential staph infection
There is a nationwide recall of SinuCleanse Soft Tip Squeeze Bottle Nasal Wash System due to the confirmed contamination of the product that can cause consumers to get staph infections.